International

Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.

image/svg+xml

Media & Investors

Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.

Press releases

Here are our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.

08 May 2023

Adhoc Press Release

Annual General Meeting of Kuros Biosciences approves all resolutions

27 Apr 2023

Adhoc Press Release

Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023

15 Mar 2023

Adhoc Press Release

Kuros Biosciences reports results for the full year 2022

21 Feb 2023

Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft

16 Feb 2023

Adhoc Press Release

Kuros Biosciences Announces Changes to Executive Management Team

23 Nov 2022

Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH

Reports, Corporate Governance & Meetings

Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.

Reports & Presentations

Corporate Governance

Shareholder Meetings

Regulatory filings

Information on disclosures under the Swiss Stock Exchange Act can be found on the website of the SIX Swiss Exchange website.

Management Transactions

Outstanding Options

Significant Shareholder Transactions

Stabilization

Analysts

Laura Pfeifer-Rossi
Octavian AG

Please use the button below to view and download Analyst reports

Reports

Investor calendar

Date Event
Aug 09, 2023 Kuros will publish its Half Year Report for H1 2023

Want to receive our press releases?